# FDA approves groundbreaking new drug for pancreatic cancer

https://mins.news/en/video/33476

- NBC News, 2026-08-26 18:19 UTC
- Health
- Original: https://www.youtube.com/watch?v=Gh64wdr6UPg

> The Food and Drug Administration approved a groundbreaking oral drug for patients with the most aggressive form of pancreatic cancer. Daraxonrasib targets a KRAS gene mutation and doubled survival time among trial participants.

## Related coverage

- [Pancreatic cancer pill offers new hope to patients](https://mins.news/en/video/34483) — CBS News, 2026-08-27
- [FDA approves breakthrough pancreatic cancer treatment](https://mins.news/en/video/33720) — NBC News, 2026-08-26
- [FDA approves Rasonque for advanced pancreatic cancer](https://mins.news/en/item/33694) — France 24, 2026-08-26
- [US drug agency approves breakthrough pancreatic cancer treatment](https://mins.news/en/item/33642) — BBC News, 2026-08-26
- [Breakthrough Pancreatic Cancer Drug Marks a New Era for Treatment](https://mins.news/en/item/33472) — Bloomberg News, 2026-08-26
- [FDA Approves RevMed’s Breakthrough Pill for Pancreatic Cancer](https://mins.news/en/item/33323) — Bloomberg News, 2026-08-26